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LETTER – HEPATOBILIARY TUMORS
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Gonzalo Sapisochin, MD, PhD4, Marwan S. Abouljoud, MD1, and Shunji Nagai, MD, PhD1
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To the Editor
We appreciate the comments of Hand et al. 1 in regard to
our recent study demonstrating that center experience
affects post-liver transplant outcomes in patients with hilar
cholangiocarcinoma (Ph-CCA).
Hand et al. 1 pointed out wide variation in volume
among well-experienced centers. We agree that well-experienced centers had a large variety of case numbers based
on our definition (six or more cases between 2010 and
2017) in our study and therefore compared post-transplant
outcomes between the largest center, other well-experienced centers, and less-experienced centers (fewer than six
cases between 2010 and 2017) to mitigate the effect of
wide variation in case volume.2 When comparing posttransplant outcomes between the largest center and the rest
of the centers in our cohort, the largest center showed a
relatively better 3- and 5-year patient survival and lower
mortality due to recurrence, but the difference was not
significant. However, in this comparison, the impact of
center experience may be diluted. As shown in Fig. 3 in
our article, there was a significant difference in outcomes
between the largest center and the less-experienced center
group, and the risk was comparable between the largest
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center and other well-experienced centers. The discrepancy
of liver transplant outcomes found in our study should be
recognized.
With regard to the recent meta-analysis involving 20
studies of unresectable Ph-CCA that demonstrated similar
survival rates between the Mayo Clinic and other centers,3
a possible explanation for the discrepancy of these results
(5-year patient survival in non-Mayo centers: Cambridge
et al. 60.6% vs. our study 33.0%) is that the meta-analysis
might underestimate the impact of center experience since
the literature was selected based on the quality and number
of cases included in each study, which might miss outcomes in transplant centers that did not have enough
experience to be reported. This may cause selection bias.
Our study investigated all transplant centers in the US and
could capture the entire experience and nationwide outcomes of liver transplant for CCA in the US. Given the
relatively small number of cases in each transplant center,
the retrospective cohort study using a national transplant
registry should more accurately reflect actual practice than
the meta-analysis.
We do not consider that surgical experience itself
determines post-transplant outcomes. Treatment strategies
for CCA require a multidisciplinary approach. While current requirements for model for end-stage liver disease
(MELD) exception score includes neoadjuvant therapy
followed by a staging laparotomy,4 it is unclear whether
accurate diagnosis based on staging laparotomy has been
uniformly performed among all transplant centers in the
US. Center experience may affect the quality of preoperative management, including diagnostic imaging studies,
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pretransplant neoadjuvant therapy, and staging laparotomy.
Therefore, appropriate patient selection and assessment
might not be well achieved in the less-experienced centers.
Although we acknowledge that multiple factors such as
different decision-making processes or unit structures
between centers might affect outcomes following liver
transplantation,5 our findings emphasize the importance of
uniform patient selection and pretransplant neoadjuvant
therapy protocol among transplant centers to achieve successful outcomes.
We acknowledge that the Organ Procurement and
Transplantation Network and United Network for Organ
Sharing (OPTN/UNOS) registry does not include detailed
information regarding oncological status and pretransplant
treatment history, which is one of the limitations of our
study. As future directions, we proposed that detailed
pretransplant treatment history and explant pathology
should be reported and monitored by OPTN/UNOS to
improve indication criteria and to determine appropriate
policy for the exception for Ph-CCA. The association
between center experience and oncological findings at the
time of transplant should be assessed in future studies.
We appreciate the comments made by Hand et al. 1 and
welcome further insight into the effect of center experience
on outcomes after liver transplantation in patients with PhCCA.
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